Gland Pharma Ltd. - Research Center
543245 GLAND Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 20 | |
|---|---|
| Sales | 1,715.71 |
| Operating profit | 710.32 |
| Interest | 1.23 |
| Gross profit | 761.52 |
| EPS (Rs) | 32.61 |
Half yearly
results in details
| Sep ' 20 | |
|---|---|
| Other income | 52.43 |
| Stock adjustment | -161.66 |
| Raw material | 845.90 |
| Power and fuel | - |
| Employee expenses | 150.90 |
| Excise | - |
| Admin and selling expenses | - |
| Research and development expenses | - |
| Expenses capitalised | - |
| Other expenses | 170.26 |
| Provisions made | - |
| Depreciation | 48.89 |
| Taxation | 180.18 |
| Net profit / loss | 532.45 |
| Extra ordinary item | - |
| Prior year adjustments | - |
| Equity capital | 16.33 |
| Equity dividend rate | - |
| Agg.of non-prom. shares (Lacs) | - |
| Agg.of non promotoholding (%) | - |
| OPM (%) | 41.40 |
| GPM (%) | 43.07 |
| NPM (%) | 30.11 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis